Dignitana AB (DIGN) - Financial and Strategic SWOT Analysis Review

November 2021 | 45 pages | ID: DC4365D48E5EN
GlobalData

Abstracts

Dignitana AB (DIGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Dignitana AB (Dignitana) is a medical technology company which focuses on the designing, developing, manufacturing and marketing of medical cooling systems. It’s DigniCap Scalp Cooling System helps reduce or eliminate hair loss in patients undergoing chemotherapy. The DigniCap system comprises a silicone cap and a connected cooling and controlling unit. It controls the temperature of the cooling cap by cooling the DigniCool coolant in the cooling and controlling unit to a suitable temperature. Dignitana’s scalp cooling technology is patented in Europe, Japan and the US. Its colling systems find application in hospitals, healthcare institutions, and medical centers. The company operates in Sweden and the US. Dignitana is headquartered in Lund, Scania, Sweden.

Dignitana AB Key Recent Developments

Oct 08,2021: Dignitana announces CFO will leave the Company
Oct 05,2021: Dignitana Names Colorado Mom and Breast Cancer Survivor as a DigniCap Dignitary
Aug 19,2021: Dignitana publishes Q2 2021 interim report
May 20,2021: Dignitana publishes Q1 2021 interim report
Nov 19,2020: Dignitana AB publishes Q3 2020 interim report

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Dignitana AB - Key Facts
Dignitana AB - Key Employees
Dignitana AB - Key Employee Biographies
Dignitana AB - Major Products and Services
Dignitana AB - History
Dignitana AB - Company Statement
Dignitana AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Dignitana AB - Business Description
Dignitana AB - SWOT Analysis
SWOT Analysis - Overview
Dignitana AB - Strengths
Dignitana AB - Weaknesses
Dignitana AB - Opportunities
Dignitana AB - Threats
Dignitana AB - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Dignitana AB, Medical Equipment, Deals By Year, 2015 to YTD 2021
Dignitana AB, Medical Equipment, Deals By Type, 2015 to YTD 2021
Dignitana AB, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Oct 08, 2021: Dignitana announces CFO will leave the Company
Oct 05, 2021: Dignitana Names Colorado Mom and Breast Cancer Survivor as a DigniCap Dignitary
Aug 19, 2021: Dignitana publishes Q2 2021 interim report
May 20, 2021: Dignitana publishes Q1 2021 interim report
Nov 19, 2020: Dignitana AB publishes Q3 2020 interim report
Aug 20, 2020: Dignitana publishes Q2 2020 interim report
Aug 12, 2020: Dignitana expands European focus with new Regional Director
Aug 07, 2020: Dignitana appoints new Chief Financial Officer
May 28, 2020: Dignitana publishes Q1 2020 interim report
May 13, 2020: Dignitana AB strengthens financial position with new loan

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Dignitana AB, Key Facts
Dignitana AB, Key Employees
Dignitana AB, Key Employee Biographies
Dignitana AB, Major Products and Services
Dignitana AB, History
Dignitana AB, Subsidiaries
Dignitana AB, Key Competitors
Dignitana AB, Ratios based on current share price
Dignitana AB, Annual Ratios
Dignitana AB, Annual Ratios (Cont...1)
Dignitana AB, Interim Ratios
Dignitana AB, Medical Equipment, Deals By Year, 2015 to YTD 2021
Dignitana AB, Medical Equipment, Deals By Type, 2015 to YTD 2021
Dignitana AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Dignitana AB, Performance Chart (2016 - 2020)
Dignitana AB, Ratio Charts
Dignitana AB, Medical Equipment, Deals By Year, 2015 to YTD 2021
Dignitana AB, Medical Equipment, Deals by Type, 2015 to YTD 2021